Robin W. van Steenhoven

ORCID: 0009-0003-6842-095X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Autoimmune Neurological Disorders and Treatments
  • Peripheral Neuropathies and Disorders
  • Genetics and Neurodevelopmental Disorders
  • Herpesvirus Infections and Treatments
  • CNS Lymphoma Diagnosis and Treatment
  • Chemokine receptors and signaling
  • Neuroinflammation and Neurodegeneration Mechanisms
  • RNA regulation and disease

Erasmus MC
2021-2025

Medisch Centrum Haaglanden
2021-2023

Amsterdam UMC Location Vrije Universiteit Amsterdam
2021-2023

Amsterdam Neuroscience
2023

Vrije Universiteit Amsterdam
2023

Leiden University
2023

Elisabeth-TweeSteden Ziekenhuis
2021

Radboud University Nijmegen
2021

Radboud University Medical Center
2021

University Medical Center
2021

The clinical criteria for autoimmune encephalitis (AE) were proposed by Graus et al. in 2016. In this study, the AE validated real world, and common mimics described. addition, probable anti-LGI1 validated.

10.1212/nxi.0000000000200148 article EN cc-by-nc-nd Neurology Neuroimmunology & Neuroinflammation 2023-08-15

Abstract Anti-Leucine-rich glioma inactivated-1 (LGI1) and anti-contactin-associated-protein-2 (CASPR2) autoimmune encephalitis (AIE) are common characterized by pathogenic antibodies targeting neuronal autoantigens. However, the drivers of antibody-secreting cells (ASC) involvement T remain unresolved. We performed single cell RNA-sequencing fresh cerebrospinal fluid (CSF) parallel blood samples 15 patients with LGI1- (n=9) CASPR2-AIE (n=6) compared to control (multiple sclerosis (MS) n=15,...

10.1093/brain/awaf096 article EN cc-by Brain 2025-03-17

Autoimmune encephalitis (AIE) may present with prominent cognitive disturbances without overt inflammatory changes in MRI and CSF. Identification of these neurodegenerative dementia diagnosis mimics is important because patients generally respond to immunotherapy. The objective this study was determine the frequency neuronal antibodies presumed describe clinical characteristics antibodies.In retrospective cohort study, 920 were included from established cohorts at 2 large Dutch academic...

10.1212/nxi.0000000000200137 article EN cc-by-nc-nd Neurology Neuroimmunology & Neuroinflammation 2023-06-13

Autoimmune encephalitis (AIE) and paraneoplastic neurologic syndromes (PNSs) encompass a heterogeneous group of antibody-associated disorders. Both the number commercially available antibody tests have increased considerably over past decade. High-quality population-based data on epidemiology these disorders real-world performance are needed.

10.1212/nxi.0000000000200318 article EN cc-by-nc-nd Neurology Neuroimmunology & Neuroinflammation 2024-10-28

Abstract Objective A substantial part of central nervous system (CNS) disorders remains unexplained, despite various new and minimally invasive diagnostic techniques. Within this rapidly developing field, the precise role brain biopsy is unknown. We aimed to study clinical impact safety biopsies in unexplained CNS disorders. Methods In retrospective cohort study, we included all adult patients who were referred for a work‐up our academic center with neuro‐inflammatory, neuro‐oncological,...

10.1002/acn3.70000 article EN cc-by Annals of Clinical and Translational Neurology 2025-02-21

<h3>Objective</h3> As autoimmune encephalitis (AIE) can resemble neurodegenerative dementia syndromes, and patients do not always present as encephalitis, this study evaluates how frequently AIE mimics provides red flags for in middle-aged older patients. <h3>Methods</h3> In nationwide observational cohort study, with anti–leucine-rich glioma-inactivated 1 (LGI1), anti–NMDA receptor (NMDAR), anti–gamma-aminobutyric acid B (GABA<sub>B</sub>R), or anti–contactin-associated protein-like 2...

10.1212/nxi.0000000000001039 article EN cc-by-nc-nd Neurology Neuroimmunology & Neuroinflammation 2021-08-02

Anti-NMDA receptor (anti-NMDAR) encephalitis generally manifests in young adults. Although 80%-90% returns to independence, the majority experience persistent cognitive and psychosocial difficulties. Studies have demonstrated that recovery may continue for years; temporal trajectory is largely unknown, as are factors influencing cognitive/psychosocial recovery. Objectives were (1) describe trajectory, (2) assess self-reported outcomes, (3) identify relating outcome, (4) explore relation...

10.1212/wnl.0000000000210109 article EN Neurology 2024-11-20
Coming Soon ...